Status: current, Primitive. Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3302017014 | Ixazomib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3302018016 | Ixazomib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ixazomib | Is a | Dichlorobenzene | true | Inferred relationship | Some | ||
| Ixazomib | Is a | Substance with benzamide structure | true | Inferred relationship | Some | ||
| Ixazomib | Is a | Proteasome inhibitor | true | Inferred relationship | Some | ||
| Ixazomib | Has disposition | Proteasome inhibitor | true | Inferred relationship | Some | ||
| Ixazomib | Is a | Immunologic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ixazomib-containing product | Has active ingredient | True | Ixazomib | Inferred relationship | Some | 1 |
| Ixazomib only product | Has active ingredient | True | Ixazomib | Inferred relationship | Some | 1 |
| Ixazomib-containing product in oral dose form | Has active ingredient | True | Ixazomib | Inferred relationship | Some | 1 |
| Ixazomib only product in oral dose form | Has active ingredient | True | Ixazomib | Inferred relationship | Some | 1 |
| Ixazomib citrate | Is modification of | True | Ixazomib | Inferred relationship | Some | |
| Ixazomib (as ixazomib citrate) 4 mg oral capsule | Has BoSS | True | Ixazomib | Inferred relationship | Some | 1 |
| Ixazomib (as ixazomib citrate) 3 mg oral capsule | Has BoSS | True | Ixazomib | Inferred relationship | Some | 1 |
| Ixazomib (as ixazomib citrate) 2.3 mg oral capsule | Has BoSS | True | Ixazomib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR